Targeting complement activation in brain-dead donors improves renal function after transplantation

Transplant Immunology

Volumn 24, Issue 4, 2011, Pages 233-237

  Damman, Jeffrey ^a   Hoeger, Simone ^b   Boneschansker, Leo ^a   Theruvath, Ashok ^b   Waldherr, Ruediger ^b   Leuvenink, Henri G ^a   Ploeg, Rutger J ^a   Yard, Benito A ^b   Seelen, Marc A ^a  

^a UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

^b UNIVERSITY OF HEIDELBERG   (Germany)

Author keywords

Brain death; Complement; Kidney; Transplantation

Indexed keywords

BETA ACTIN; CELL PROTEIN; COMPLEMENT COMPONENT C3B RECEPTOR; COMPLEMENT COMPONENT C3D; CREATININE; ENDOTHELIAL LEUKOCYTE ADHESION MOLECULE 1; INTERLEUKIN 1BETA; INTERLEUKIN 6; MONOCYTE CHEMOTACTIC PROTEIN 1; PROTEIN KIM 1; TRANSFORMING GROWTH FACTOR BETA; UNCLASSIFIED DRUG; UREA;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; ARTIFICIAL VENTILATION; BALLOON CATHETER; BRAIN DEATH; CADAVER KIDNEY; COMPLEMENT ACTIVATION; CONTROLLED STUDY; CREATININE BLOOD LEVEL; GENE EXPRESSION; GRAFT RECIPIENT; HISTOPATHOLOGY; KIDNEY ALLOGRAFT; KIDNEY FUNCTION; KIDNEY TRANSPLANTATION; MALE; NONHUMAN; POSTOPERATIVE PERIOD; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; RAT; SINGLE DRUG DOSE; UREA BLOOD LEVEL;

ANIMALS; BALLOON DILATION; BRAIN DEATH; CELLS, CULTURED; COMPLEMENT ACTIVATION; CYTOKINES; HUMANS; INFLAMMATION MEDIATORS; KIDNEY; KIDNEY TRANSPLANTATION; ORGAN PRESERVATION; RATS; RATS, INBRED STRAINS; RECEPTORS, COMPLEMENT; RECOVERY OF FUNCTION; TISSUE AND ORGAN HARVESTING;

EID: 79955480837     PISSN: 09663274     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.trim.2011.03.001     Document Type: Article

References (25)

1. Terasaki P.I., Cecka J.M., Gjertson D.W., Takemoto S. High survival rates of kidney transplants from spousal and living unrelated donors. N Engl J Med 1995 Aug 10, 333(6):333-336.
2. Matas A.J., Gillingham K.J., Humar A., Dunn D.L., Sutherland D.E., Najarian J.S. Immunologic and nonimmunologic factors: different risks for cadaver and living donor transplantation. Transplantation 2000 Jan 15, 69(1):54-58.
3. Nijboer W.N., Schuurs T.A., van der Hoeven J.A., Fekken S., Wiersema-Buist J., Leuvenink H.G., et al. Effect of brain death on gene expression and tissue activation in human donor kidneys. Transplantation 2004 Oct 15, 78(7):978-986.
4. Kusaka M., Pratschke J., Wilhelm M.J., Ziai F., Zandi-Nejad K., Mackenzie H.S., et al. Activation of inflammatory mediators in rat renal isografts by donor brain death. Transplantation 2000 Feb 15, 69(3):405-410.
5. Hoeger S., Bergstraesser C., Selhorst J., Fontana J., Birck R., Waldherr R., et al. Modulation of brain dead induced inflammation by vagus nerve stimulation. Am J Transplant 2010 Mar, 10(3):477-489.
6. Schuurs T.A., Gerbens F., van der Hoeven J.A., Ottens P.J., Kooi K.A., Leuvenink H.G., et al. Distinct transcriptional changes in donor kidneys upon brain death induction in rats: insights in the processes of brain death. Am J Transplant 2004 Dec, 4(12):1972-1981.
7. Damman J., Nijboer W.N., Schuurs T.A., Leuvenink H.G., Morariu A.M., Tullius S.G., et al. Local renal complement C3 induction by donor brain death is associated with reduced renal allograft function after transplantation. Nephrol Dial Transplant 2010 Dec 2.
8. Walport M.J. Complement. First of two parts. N Engl J Med 2001 Apr 5, 344(14):1058-1066.
9. Walport M.J. Complement. Second of two parts. N Engl J Med 2001 Apr 12, 344(15):1140-1144.
10. Zhou W., Farrar C.A., Abe K., Pratt J.R., Marsh J.E., Wang Y., et al. Predominant role for C5b-9 in renal ischemia/reperfusion injury. J Clin Invest 2000 May, 105(10):1363-1371.
11. Pratt J.R., Basheer S.A., Sacks S.H. Local synthesis of complement component C3 regulates acute renal transplant rejection. Nat Med 2002 Jun, 8(6):582-587.
12. Serinsoz E., Bock O., Gwinner W., Schwarz A., Haller H., Kreipe H., et al. Local complement C3 expression is upregulated in humoral and cellular rejection of renal allografts. Am J Transplant 2005 Jun, 5(6):1490-1494.
13. Arumugam T.V., Shiels I.A., Strachan A.J., Abbenante G., Fairlie D.P., Taylor S.M. A small molecule C5a receptor antagonist protects kidneys from ischemia/reperfusion injury in rats. Kidney Int 2003 Jan, 63(1):134-142.
14. Gueler F., Rong S., Gwinner W., Mengel M., Brocker V., Schon S., et al. Complement 5a receptor inhibition improves renal allograft survival. J Am Soc Nephrol 2008 Dec, 19(12):2302-2312.
15. de Vries B., Matthijsen R.A., Wolfs T.G., van Bijnen A.A., Heeringa P., Buurman W.A. Inhibition of complement factor C5 protects against renal ischemia-reperfusion injury: inhibition of late apoptosis and inflammation. Transplantation 2003 Feb 15, 75(3):375-382.
16. Pratt J.R., Hibbs M.J., Laver A.J., Smith R.A., Sacks S.H. Allograft immune response with sCR1 intervention. Transpl Immunol 1996 Mar, 4(1):72-75.
17. Zheng X., Feng B., Chen G., Zhang X., Li M., Sun H., et al. Preventing renal ischemia-reperfusion injury using small interfering RNA by targeting complement 3 gene. Am J Transplant 2006 Sep, 6(9):2099-2108.
18. Zheng X., Zhang X., Feng B., Sun H., Suzuki M., Ichim T., et al. Gene silencing of complement C5a receptor using siRNA for preventing ischemia/reperfusion injury. Am J Pathol 2008 Oct, 173(4):973-980.
19. Weisman H.F., Bartow T., Leppo M.K., Marsh H.C., Carson G.R., Concino M.F., et al. Soluble human complement receptor type 1: in vivo inhibitor of complement suppressing post-ischemic myocardial inflammation and necrosis. Science 1990 Jul 13, 249(4965):146-151.
20. Gottmann U., Brinkkoetter P.T., Hoeger S., Gutermann K., Coutinho Z.M., Ruf T., et al. Atorvastatin donor pretreatment prevents ischemia/reperfusion injury in renal transplantation in rats: possible role for aldose-reductase inhibition. Transplantation 2007 Sep 27, 84(6):755-762.
21. Gottmann U., Mueller-Falcke A., Schnuelle P., Birck R., Nickeleit V., van der Woude F.J., et al. Influence of hypersulfated and low molecular weight heparins on ischemia/reperfusion: injury and allograft rejection in rat kidneys. Transpl Int 2007 Jun, 20(6):542-549.
22. Liu Z., Hoeger S., Schnuelle P., Feng Y., Goettmann U., Waldherr R., et al. Donor dopamine pretreatment inhibits tubulitis in renal allografts subjected to prolonged cold preservation. Transplantation 2007 Feb 15, 83(3):297-303.
23. Kinoshita T. Biology of complement: the overture. Immunol Today 1991 Sep, 12(9):291-295.
24. Lazar H.L., Bokesch P.M., van Lenta F., Fitzgerald C., Emmett C., Marsh H.C., et al. Soluble human complement receptor 1 limits ischemic damage in cardiac surgery patients at high risk requiring cardiopulmonary bypass. Circulation 2004 Sep 14, 110(11 Suppl. 1):II274-II279.
25. Zimmerman J.L., Dellinger R.P., Straube R.C., Levin J.L. Phase I trial of the recombinant soluble complement receptor 1 in acute lung injury and acute respiratory distress syndrome. Crit Care Med 2000 Sep, 28(9):3149-3154.